2020
DOI: 10.1186/s43141-020-0021-4
|View full text |Cite
|
Sign up to set email alerts
|

In silico analysis of a novel causative mutation in Cadherin23 gene identified in an Omani family with hearing loss

Abstract: Background: Hereditary hearing loss is a heterogeneous group of complex disorders with an overall incidence of one in every 500 newborns presented as syndromic and non-syndromic forms. Cadherin-related 23 (CDH23) is one of the listed deafness causative genes. It is found to be expressed in the stereocilia of hair cells and in the retina photoreceptor cells. Defective CDH23 have been associated mostly with prelingual severe-to-profound sensorineural hearing loss (SNHL) in either syndromic (USH1D) or non-syndrom… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 62 publications
(67 reference statements)
0
0
0
Order By: Relevance
“…This was reported previously in other NSHL patients from the USA and Japanese populations (Schultz et al, 2011;Wagatsuma et al, 2007). Two different homozygous variants (p.Pro2205Leu; p.Asp2479Ala) were identified in three Qatari and two Omani NSHL families, respectively (Al-Kindi et al, 2020;Alkowari et al, 2017). These were private variants for this type of cohort that arise probably due to a founder effect (Al Mutery et al, 2022).…”
Section: Cadherin 23supporting
confidence: 81%
“…This was reported previously in other NSHL patients from the USA and Japanese populations (Schultz et al, 2011;Wagatsuma et al, 2007). Two different homozygous variants (p.Pro2205Leu; p.Asp2479Ala) were identified in three Qatari and two Omani NSHL families, respectively (Al-Kindi et al, 2020;Alkowari et al, 2017). These were private variants for this type of cohort that arise probably due to a founder effect (Al Mutery et al, 2022).…”
Section: Cadherin 23supporting
confidence: 81%